GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (FRA:7D2A) » Definitions » Capital Expenditure

Sedana Medical AB (FRA:7D2A) Capital Expenditure : €-12.36 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Sedana Medical AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Sedana Medical AB's cash flow for capital expenditures for the three months ended in Mar. 2025 was €-1.54 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was €-12.36 Mil.

Sedana Medical AB Capital Expenditure Historical Data

The historical data trend for Sedana Medical AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Capital Expenditure Chart

Sedana Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.32 -10.74 -12.53 -15.10 -15.21

Sedana Medical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.60 -4.94 -3.26 -2.62 -1.54

Sedana Medical AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sedana Medical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (FRA:7D2A) » Definitions » Capital Expenditure
Comparable Companies
OSTO:BACTI B OSTO:OSSD OSTO:CRAD B OSTO:PAX OSTO:SEZI OSTO:INTEG B OSTO:BRAIN OSTO:MNTC OSTO:PRO OSTO:BOUL ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
SEDANA:Sweden
Address
Vendevagen 89, Danderyd, SWE, SE-182 32
Website
https://www.sedanamedical.com
Sedana Medical AB is a Sweden-based medical technology company. It is a pioneer MedTech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. The product range of the group is Sedaconda ACD, Sedaconda, AnaConDa, FlurAbsorb, Gas Monitor, Adapters, and Accessories. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB Headlines

No Headlines